Lithium Ion

Lithium Ion

SCHEMBL8569232

[CH2]CCCC(=O)[O-].[Li+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11224758 0.94
Lithium Ion SCHEMBL8573919 0.89 CA1 (0.44)
SCHEMBL8571575 0.86
SCHEMBL29039269 0.83 CA1 (0.50)
Adipic Acid SCHEMBL105603 0.81 CA1 (0.58)
Glutarate SCHEMBL106537 0.81 CA1 (0.58)
Lithium Ion SCHEMBL11431855 0.78 CA1 (0.55)
Adipic Acid SCHEMBL105951 0.78 CA1 (0.55)
Glutarate SCHEMBL107713 0.78 CA1 (0.55)
Sebacic Acid SCHEMBL1938485 0.78 CA1 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843951-A Analgesic composition of pyrazolo(1,5-A) pyrimidines OTSUKA PHARMACEUTICAL FACTORY INC. (JP) 1998-12-01 US disclosed
EP-0795555-A1 ANALGESICS OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1997-09-17 EP disclosed